FindTrial
Sign In

Effect of Ghritabhrushta Haritaki Bidalaka in Krimigranthi (Blepharitis).

A RANDOMISED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFECT OF GHRITABHRUSHTA HARITAKI BIDALAKA IN KRIMIGRANTHI WITH SPECIAL REFERENCE TO BLEPHARITIS. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101944
Enrollment
70
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Sponsors

Dr Poonam Raosaheb Shinde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical sign and symptoms of Krimigranthi 1) Itching at eyelid 2)Burning sensation to eyes 3)Pain in eye 4)Watering of the eyes 5) Inflammation of eyelid 6) Falling of eyelashes

Exclusion criteria

Exclusion criteria: Patients will be excluded from the study if they have 1)Psoriasis or other major skin disorders. 2)Patient suffering with complications of Blepharitis such as Conjuctivities, Marginal Keratitis.

Design outcomes

Primary

MeasureTime frame
Reduction in Sign and Symptoms of Krimigranthi after application of Ghritabhrushta Haritaki Bidalaka with the help of assesment criteria.Timepoint: 7 Days—

Secondary

MeasureTime frame
Where the trial group stands in comparison with control group in Reduction of signs and symptoms of Krimigranthi.Timepoint: 18 months.—

Countries

India

Contacts

Public ContactDr Poonam Raosaheb Shinde

SMBT Ayurved College and Hospital

dr.tusharfirke@gmail.com9823388720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026